Middle East & Africa Liver Cancer Diagnostics Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2028 – COVID-19 Impact and Analysis – by Type (Laboratory Tests, Endoscopy, Imaging, Biopsy, and Others) and End User (Hospitals and Diagnostic Laboratories, Academic and Research Institutes, and CRO Laboratories)

No. of Pages: 130    |    Report Code: BMIRE00025042    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Middle East & Africa Liver Cancer Diagnostics Market

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. Middle East & Africa Liver Cancer Diagnostics Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. Middle East & Africa Liver Cancer Diagnostics Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1 Increasing Diagnosis Due to Strategic Initiatives
  • 5.1.2 Increasing Liver Cancer Cases
5.2 Market Opportunities
  • 5.2.1 Increasing Research And Development (R&D) Expenditure
5.3 Future Trends
  • 5.3.1 Rising Emergence of New Technologies is the Trends Witnessed
5.4 Impact of Drivers and Restraints

6. Middle East & Africa Liver Cancer Diagnostics Market Regional Analysis

6.1 Middle East & Africa Liver Cancer Diagnostics Market Overview
6.2 Middle East & Africa Liver Cancer Diagnostics Market Revenue 2019-2028 (US$ Million)
6.3 Middle East & Africa Liver Cancer Diagnostics Market Forecast Analysis

7. Middle East & Africa Liver Cancer Diagnostics Market Analysis – by Type

7.1 Laboratory Tests
  • 7.1.1 Overview
  • 7.1.2 Laboratory Tests: Middle East & Africa Liver Cancer Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Endoscopy
  • 7.2.1 Overview
  • 7.2.2 Endoscopy: Middle East & Africa Liver Cancer Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Imaging
  • 7.3.1 Overview
  • 7.3.2 Imaging: Middle East & Africa Liver Cancer Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Biopsy
  • 7.4.1 Overview
  • 7.4.2 Biopsy: Middle East & Africa Liver Cancer Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)

8. Middle East & Africa Liver Cancer Diagnostics Market Analysis – by End User

8.1 Hospitals and Diagnostic Laboratories
  • 8.1.1 Overview
  • 8.1.2 Hospitals and Diagnostic Laboratories: Middle East & Africa Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.2 Academic and Research Institutes
  • 8.2.1 Overview
  • 8.2.2 Academic and Research Institutes: Middle East & Africa Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.3 CRO Laboratories
  • 8.3.1 Overview
  • 8.3.2 CRO Laboratories : Middle East & Africa Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9. Middle East & Africa Liver Cancer Diagnostics Market – Middle East and Africa Analysis

9.1 Middle East and Africa
  • 9.1.1 Middle East & Africa Liver Cancer Diagnostics Market Breakdown, by Key Country, 2022 and 2028 (%)
  • 9.1.1.1 Middle East & Africa Liver Cancer Diagnostics Market – Revenue and Forecast Analysis – by Country
  • 9.1.1.1 South Africa: Middle East & Africa Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
    • 9.1.1.1.1 South Africa: Middle East & Africa Liver Cancer Diagnostics Market Breakdown, by Type
    • 9.1.1.1.2 South Africa: Middle East & Africa Liver Cancer Diagnostics Market Breakdown, by End User
  • 9.1.1.2 Saudi Arabia: Middle East & Africa Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
    • 9.1.1.2.1 Saudi Arabia: Middle East & Africa Liver Cancer Diagnostics Market Breakdown, by Type
    • 9.1.1.2.2 Saudi Arabia: Middle East & Africa Liver Cancer Diagnostics Market Breakdown, by End User
  • 9.1.1.3 UAE: Middle East & Africa Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
    • 9.1.1.3.1 UAE: Middle East & Africa Liver Cancer Diagnostics Market Breakdown, by Type
    • 9.1.1.3.2 UAE: Middle East & Africa Liver Cancer Diagnostics Market Breakdown, by End User
  • 9.1.1.4 Rest of Middle East and Africa: Middle East & Africa Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
    • 9.1.1.4.1 Rest of Middle East and Africa: Middle East & Africa Liver Cancer Diagnostics Market Breakdown, by Type
    • 9.1.1.4.2 Rest of Middle East and Africa: Middle East & Africa Liver Cancer Diagnostics Market Breakdown, by End User

10. Competitive Landscape

10.1 Heat Map Analysis
10.2 Company Positioning and Concentration

11. Middle East & Africa Liver Cancer Diagnostics Market Industry Landscape

11.1 Overview
11.2 Mergers and Acquisitions
11.3 Agreements, Collaborations, and Joint Ventures
11.4 New Product Launches
11.5 Expansions and Other Strategic Developments

12. Company Profiles

12.1 Abbott
  • 12.1.1 Key Facts
  • 12.1.2 Business Description
  • 12.1.3 Products and Services
  • 12.1.4 Financial Overview
  • 12.1.5 SWOT Analysis
  • 12.1.6 Key Developments
12.2 bioMerieux SA
  • 12.2.1 Key Facts
  • 12.2.2 Business Description
  • 12.2.3 Products and Services
  • 12.2.4 Financial Overview
  • 12.2.5 SWOT Analysis
  • 12.2.6 Key Developments
12.3 F. HOFFMANN-LA ROCHE LTD.
  • 12.3.1 Key Facts
  • 12.3.2 Business Description
  • 12.3.3 Products and Services
  • 12.3.4 Financial Overview
  • 12.3.5 SWOT Analysis
  • 12.3.6 Key Developments
12.4 Illumina, Inc.
  • 12.4.1 Key Facts
  • 12.4.2 Business Description
  • 12.4.3 Products and Services
  • 12.4.4 Financial Overview
  • 12.4.5 SWOT Analysis
  • 12.4.6 Key Developments
12.5 Koninklijke Philips N.V.
  • 12.5.1 Key Facts
  • 12.5.2 Business Description
  • 12.5.3 Products and Services
  • 12.5.4 Financial Overview
  • 12.5.5 SWOT Analysis
  • 12.5.6 Key Developments
12.6 QIAGEN
  • 12.6.1 Key Facts
  • 12.6.2 Business Description
  • 12.6.3 Products and Services
  • 12.6.4 Financial Overview
  • 12.6.5 SWOT Analysis
  • 12.6.6 Key Developments
12.7 Siemens Healthineers AG
  • 12.7.1 Key Facts
  • 12.7.2 Business Description
  • 12.7.3 Products and Services
  • 12.7.4 Financial Overview
  • 12.7.5 SWOT Analysis
  • 12.7.6 Key Developments
12.8 THERMO FISHER SCIENTIFIC INC.
  • 12.8.1 Key Facts
  • 12.8.2 Business Description
  • 12.8.3 Products and Services
  • 12.8.4 Financial Overview
  • 12.8.5 SWOT Analysis
  • 12.8.6 Key Developments
12.9 GE Healthcare
  • 12.9.1 Key Facts
  • 12.9.2 Business Description
  • 12.9.3 Products and Services
  • 12.9.4 Financial Overview
  • 12.9.5 SWOT Analysis
  • 12.9.6 Key Developments
12.10 Perspectum
  • 12.10.1 Key Facts
  • 12.10.2 Business Description
  • 12.10.3 Products and Services
  • 12.10.4 Financial Overview
  • 12.10.5 SWOT Analysis
  • 12.10.6 Key Developments

13. Appendix

13.1 About Business Market Insights

The List of Companies - M Market

  1. Abbott
  2. bioMerieux SA
  3. F. HOFFMANN-LA ROCHE LTD.
  4. Illumina, Inc.
  5. Koninklijke Philips N.V.
  6. QIAGEN
  7. Siemens Healthineers AG
  8. THERMO FISHER SCIENTIFIC INC.
  9. GE Healthcare
  10. Perspectum